scholarly journals 12 - Immunosuppressive (IS) therapy impacts the results of Quantiferon® and tuberculin skin test in routine screening for latent tuberculosis (LTB) in patients with inflammatory bowel diseases (IBD)

2009 ◽  
Vol 3 (1) ◽  
pp. S8
Author(s):  
P. Papay ◽  
A. Eser ◽  
W. Miehsler ◽  
C. Lichtenberger ◽  
A. Mikulits ◽  
...  
Keyword(s):  
Tuberculin Skin Test ◽  
Skin Test ◽  
Inflammatory Bowel Diseases ◽  
Latent Tuberculosis ◽  
Routine Screening ◽  
Bowel Diseases ◽  
Inflammatory Bowel

501 Discrepant Results Between Routine Screening for Latent Tuberculosis (Tb) and Quantiferon® in Patients with Inflammatory Bowel Diseases (IBD)

2008 ◽  
Vol 134 (4) ◽  
pp. A-69
Author(s):  
Pavol Papay ◽  
Alexander Eser ◽  
Petra Paulinska ◽  
Cornelia Lichtenberger ◽  
Andrea Mikulits ◽  
...  
Keyword(s):  
Inflammatory Bowel Diseases ◽  
Latent Tuberculosis ◽  
Routine Screening ◽  
Bowel Diseases ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document